Biosynex SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 42.7 million compared to EUR 142.2 million a year ago. Net loss was EUR 19.3 million compared to net income of EUR 30.6 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.325 EUR | +0.30% |
|
+10.62% | -61.32% |
May. 28 | Biosynex: obtains CE markings under the new IVDR regulations | CF |
May. 13 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
1st Jan change | Capi. | |
---|---|---|
-61.32% | 38.65M | |
-8.05% | 11.78B | |
-22.07% | 6.59B | |
+27.13% | 5.46B | |
-24.14% | 3.45B | |
+4.11% | 2.5B | |
+31.97% | 2.29B | |
-67.03% | 2.21B | |
-13.15% | 2.2B | |
-17.96% | 1.59B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023